Escitalopram (Cipralex®, Lexapro®), behandeling depressie


1. IB-teksten escitalopram (Cipramil® en Lexapro®) via: www.cbg-meb.nl, Geneesmiddeleninformatiebank. 
2. Burke WJ, et al. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002; 63: 331-336. 
3. Lepola UM, et al. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primay care. Int Clin Psychopharrmacol 2003; 18: 211-217. 
4. Montgomery SA, et al. A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder. Neuropsychobiology 2004; 50: 57-64. 
5. Stahl SM, et al. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2003; 64: 1322-1327. 
6. Lader M, et al. Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study. Depress Anxiety 2004; 19: 241-248. 
7. NHG-Standaard Depressieve stoornis. Huisarts Wet 2003; 46: 614-623. 
8. NHG-Standaard Angststoornissen (eerste herziening). Huisarts Wet 2004; 47: 26-37. 

Auteurs

  • dr D. Bijl